The association between diabetes and breast cancer stage at diagnosis: a population-based study

Published: March 17, 2015
Category: Bibliography > Papers
Authors: Austin PC, Fischer HD, Fu L, Ginsburg O, Jaakkimainen RL, Lipscombe LL, Narod S, Paszat L, Rochon PA
Countries: Canada
Language: null
Types: Population Health
Settings: Hospital, PCP

Breast Cancer ResTreat 150:613-620.

Women’s College Research Institute, Women’s College Hospital, Toronto, ON, Canada

Women with diabetes have higher breast cancer incidence and mortality. The purpose of this study was to examine the impact of diabetes on stage at breast cancer diagnosis, as a possible reason for their higher mortality. Using population-based health databases from Ontario, Canada, this retrospective cohort study examined stage at diagnosis (II, III, or IV vs I) among women aged 20-105 years who were newly diagnosed with invasive breast cancer between 2007 and 2012. We compared those with diabetes to those without diabetes. Diabetes was defined based on medical records using a validated algorithm. Among 38,407 women with breast cancer, 6115 (15.9 %) women had diabetes. Breast cancer patients with diabetes were significantly more likely to present with advanced-stage breast cancer than those without diabetes. After adjustment for mammograms and other covariates, diabetes was associated with a significantly increased risk of Stage II [adjusted odds ratio (aOR) 1.14, 95 % confidence interval (CI) 1.07, 1.22], Stage III (aOR 1.21, 95 % CI 1.11, 1.33), and Stage IV (aOR 1.16, 95 % CI 1.01, 1.33) versus Stage I breast cancer. Women with diabetes had a higher risk of lymph node metastases (aOR 1.16, 95 % CI 1.06, 1.27) and tumors with size over 2 cm (aOR 1.16, 95 % CI 1.06, 1.28). Diabetes was associated with more advanced-stage breast cancer, even after accounting for differences in screening mammogram use and other factors. Our findings suggest that diabetes may predispose to more aggressive breast cancer, which may be a contributor to their higher cancer mortality.

PMID: 25779100

Canada,Gender,Co-morbidity,Mortality Prediction,Chronic Disease Patients,Adult,Aged,80 and over,Co-morbidity,Cross-Sectional Studies,Middle Aged,Neopalsm Staging,Ontario/epidemiology,Prognosis,Retrospective Studies,Risk Factors,Young Adult

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top